ArticleEpigenetics & chromatin2025
Functional characterization of transcriptional enhancers in an Anopheles genetic locus controlling natural resistance to the malaria parasite, Plasmodium falciparum.
Article in Epigenetics & chromatin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAnopheles mosquitoes and the malaria parasites they transmit remain a significant global health problem. Most genomic and functional genomic studies of mosquitoes have focused on the protein-coding genome, and comparatively little is known about the importance of noncoding transcriptional enhancers in controlling their gene expression and phenotypic variation. Here we evaluate nine enhancers previously identified in a STARR-seq screen and present in a genetic locus that was identified as a major influence on susceptibility to malaria infection in wild Anopheles coluzzii mosquitoes.
resultWe developed an analytical pipeline to filter nine enhancers in the malaria susceptibility locus on chromosome 2L. First, ATAC-seq revealed that only three of the nine enhancers were located in open chromatin and thus likely to be active in somatic cells. Next, we cloned these three enhancers from malaria-susceptible and resistant mosquitoes and measured their enhancer activity by luciferase reporter assays. Only two of the three open-chromatin enhancers displayed significantly different enhancer activity between resistant and susceptible alleles. Finally, alleles of just one of these enhancers, ENH_2L-03, contained nucleotide variants which also segregated in wild mosquitoes, and ENH_2L-03 was prioritized for further study. A noncoding RNA was detected within ENH_2L-03, consistent with an enhancer RNA (eRNA), which we depleted in mosquitoes using RNAi in order to silence the enhancer activity. Transcriptional profiling of ENH_2L-03-silenced mosquitoes revealed 15 differentially expressed genes, which share a transcription factor binding motif suggestive of coordinate regulation. However, silencing ENH_2L-03 did not influence infection levels of either human or rodent malaria parasites.
conclusionDespite the absence of an ENH_2L-03 effect on infection outcome, multiple enhancers can cooperate to influence a phenotype, and further examination of this enhancer is warranted. Overall, we provide a pipeline for the in vivo functional study of transcriptional enhancers in Anopheles, towards understanding how enhancer function may control important vector phenotypes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.